Pharma Predictions for 2021
Summary: In a return to our popular event during JP Morgan 2020, Endpoints Editor John Carroll sat down with Catalent CEO John Chiminski to talk about the year ahead, offering their projections for what 2021 holds in store for the biopharma industry.